Hot Products

Calcitriol
Catalog No: CFN60322

Calcium pantothenate
Catalog No: CFN91751

Calcium pantothenate, a vitamin, can reduce the patulin content of the apple juice.In vitro: In human dermal fibroblasts from three different donors, Calcium pantothenate accelerates the wound healing process by increasing the number of migrating cells, their distance and hence their speed. In addition, cell division is increased and the protein synthesis changed.Pantothenic acid shows anti-radiation and antioxidant effects, which can protect cells from cell damage induced by reactive oxygen species IC50 & Target: Human Endogenous Metabolite
Calenduloside E
Catalog No: CFN91169

Calenduloside E, a potent anti-apoptotic agent, has anti-tumour and anti-angiogenic activities, it can protect against ox-LDL-induced human umbilical vein endothelial cell (HUVEC) injury in our previous reports. Calenduloside E has anti-inflammary activity, it inhibits LPS-induced inflammatory response by blocking ROS-mediated activation of JAK1-stat3 signaling pathway in RAW264.7 cells. Calenduloside E analogues provide protection to H9c2 cardiomyocytes against H2O2-induced oxidative stress and apoptosis, most likely via anti-apoptotic mechanism.
Calycanthine
Catalog No: CFN90940

D-calycanthine has antifungal activity, it shows significant inhibitory activities against five plant pathogenic fungi Exserohilum turcicum, Bipolaris maydis, Alternaria solani, Sclerotinia sderotiorum, and Fusarium oxysportium.
Calycanthoside
Catalog No: CFN98764

Isofraxidin-7-O-glucoside(Calycanthoside ) has the anti-inflammatory effect, it has inhibitory activity on NO production.It also shows antibacterial activity.
Calycosin
Catalog No: CFN99140

Calycosin, a selective estrogen receptor modulator, is also a vasorelaxant and a noncompetitive Ca(2+) channel blocker. It has anti-oxidative, anti-inflammatory, hepatoprotective,antineoplastic, and effective skin-lightening activities. Calycosin exhibited tyrosinase inhibitory activity with an IC(50) value of 38.4 microM, it suppressed breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
Calycosin-7-O-beta-D-glucoside
Catalog No: CFN99141

Calycosin-7-O-beta-D-glucoside, a melanin biosynthesis inhibitor, can protect BBB integrity in experimental cerebral ischemia–reperfusion injury via regulating NO/cav-1/MMPs pathway. It attenuates ischemia-reperfusion injuryin vivovia activation of the PI3K/Akt pathway, and has effects on cell apoptosis in cervical cancer HeLa cells and expression of Bcl-2/Bax.
Calystegine A3
Catalog No: CFN00166

Calystegines A3, B2, and C1 are glycosidase inhibitors. Calystegines A3 and B2 can effectively stabilize β-glucocerebrosidase, and consequently increase intracellular β-glucocerebrosidase activities in N370S fibroblasts.
Calystegine A5
Catalog No: CFN00169

Reference standards.
Calystegine B1
Catalog No: CFN00164

Calystegine B1 is a noncompetitive inhibitor of rice alpha-glucosidase, with a Ki value of 0.9 +/- 0.1 microM. Calystegine B1 and Calystegine C1 are potent competitive inhibitors of the bovine, human, and rat beta-glucosidase activities, with Ki values of 150, 10, and 1.9 microM.